RECANATI LEON bought EVGN
September 4, 2026 · Form 4 insider transaction
RECANATI LEON bought 2,500 shares of Evogene Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 26 days after the transaction.
Footnotes
The exercise price of the options to purchase Ordinary Shares of the Issuer (the "Options") reported in this row is New Israeli Shekels ("NIS") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date.; The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options. The Options were granted pursuant to, and are subject to the terms of, the Issuer's 2021 Share Incentive Plan,; The Options vest and become exercisable on a quarterly basis (25% per quarter), commencing on September 4, 2026, such that the Options will be fully vested on September 4, 2027, the one-year anniversary of the grant date.